Oncology & Cancer

Right-sided colorectal tumors: An internal radiation advantage

For patients with colorectal cancer that has metastasized to the liver, having a primary tumour on the left side, as opposed to the right side of the colon, is known to be a significant advantage in terms of treatment response.

Oncology & Cancer

More chemo drugs don't improve treatment of rare bone cancer

Osteosarcoma patients with tumors that haven't responded well to the standard chemotherapy regimen have unimproved outcomes and more side effects when given two additional drugs, a large international trial has found.

Neuroscience

Study confirms long-term effects of 'chemobrain' in mice

Women undergoing chemotherapy for breast cancer have long complained of lingering cognitive impairments after treatment. These effects are referred to as "chemobrain," a feeling of mental fogginess. A new study from the University ...

Oncology & Cancer

Analytics approach could improve chemo combinations

(HealthDay)—Models based on machine learning and optimization could improve chemotherapy regimens to be tested in phase III clinical trials without altering the toxicity outcomes, according to a study published in the May ...

Oncology & Cancer

PET scans guiding chemo boosts remission for Hodgkin patients

Using PET imaging to guide chemotherapy treatment significantly increases the number of people who go into remission and also decreases toxic side effects for people with advanced Hodgkin lymphoma, according to research conducted ...

Oncology & Cancer

ASCO: new regimen effective for locally advanced rectal cancer

(HealthDay)—For patients with rectal cancer, short-course radiation followed by chemotherapy appears similar in effectiveness to a five-week chemoradiation regimen, according to a study presented at the American Society ...

page 3 from 10